ASAM Weekly November 28, 2023
SAMHSA recently released results from the 2022 National Survey on Drug Use and Health (NSDUH). While further analysis of the data is expected to follow, many of our featured publications this week provide important context for the numbers.
Marijuana continues to be the most commonly used illicit substance in the US, bringing with it unique public health concerns. Researchers from the largest genetic study of cannabis use disorders (CUD) found a potential link between CUD and lung cancer and expanded upon our understanding of psychopathology and cannabis use (Nature Genetics). The CDC published an important yet unfortunate case report on the death of an employee from cannabis-related occupational asthma, and also found evidence of symptoms in other co-workers (MMWR).
Recent and Past Issues
-
ASAM Weekly for November 28, 2023
SAMHSA recently released results from the 2022 National Survey on Drug Use and Health (NSDUH). While further analysis of the data is expected to follow, many of our featured publications this week provide important context for the numbers.Full story -
ASAM Weekly for November 21, 2023
If you're a little apprehensive this year about having awkward or even anxiety-provoking Thanksgiving conversations, then we’ve got you covered.Full story -
ASAM Weekly for November 14, 2023
How we frame the problem significantly impacts individuals with addiction. A global review of legislative approaches toward gambling demonstrates how some countries are still warming to a systemic, public health approach while many are mostly focused on vulnerable individuals and promoting responsible gambling (Lancet Public Health).Full story -
ASAM Weekly for November 7, 2023
As we presented last week, ASAM provides expert guidance for the field of addiction medicine. Today, the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) published the Clinical Practice Guideline on the Management of Stimulant Use Disorder.Full story -
ASAM Weekly for October 31, 2023
If you haven’t recently explored the ASAM website, this week’s publications may be a good motivation to do so.Full story -
ASAM Weekly for October 24, 2023
Stuff happens as we move substance use along the spectrum between criminalization and commercialization.Full story -
ASAM Weekly for October 17, 2023
There’s something remarkable about identifying a common brain network underlying substance use disorders (Nature Mental Health). This commonality was not a given -- the results could have gone the other way -- but its existence is reassuring for how it unifies the disorders of addiction.Full story -
ASAM Weekly for October 10, 2023
A study from New York has found that increasing temperatures are associated with increased hospital visits related to alcohol and substance use (Communications Medicine)...Full story -
ASAM Weekly for October 3, 2023
Tucked within social determinants of health are commercial determinants which have a particular interest in “addictiveness.” This is clearly evident in the lead article demonstrating how tobacco companies shifted the US food industry towards hyperpalatability beginning in the 1980s (Addiction).Full story -
ASAM Weekly for September 26th, 2023
Both the RAND Corporation and SAMHSA recently released reports providing broad perspectives on addiction in America. At over 600 pages, “America’s Opioid Ecosystem” (RAND) is a comprehensive review of the dynamic systems and issues underlying not only America’s opioid crisis but the entire addiction ecosystem.Full story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the ASAM Weekly
The ASAM Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFASAM
Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Publications Chair: Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors: Brandon
Aden, MD, Debra R. Newman, PA-C, MSPAS, MPH, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ASAMWeekly@ASAM.org
The ASAM Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ASAM representative.
To learn more about advertising opportunities
Contact: Bob Davis at Bdavis@ASAM.org